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Abstract
Background
Digitally enabled rehabilitation may lead to better outcomes but has not been tested in large
pragmatic trials. We aimed to evaluate a tailored prescription of affordable digital devices in
addition to usual care for people with mobility limitations admitted to aged care and neuro-
logical rehabilitation.
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Methods and findings
We conducted a pragmatic, outcome-assessor-blinded, parallel-group randomised trial in 3
Australian hospitals in Sydney and Adelaide recruiting adults 18 to 101 years old with mobil-
ity limitations undertaking aged care and neurological inpatient rehabilitation. Both the inter-
vention and control groups received usual multidisciplinary inpatient and post-hospital
rehabilitation care as determined by the treating rehabilitation clinicians. In addition to usual
care, the intervention group used devices to target mobility and physical activity problems,
individually prescribed by a physiotherapist according to an intervention protocol, including
virtual reality video games, activity monitors, and handheld computer devices for 6 months
in hospital and at home. Co-primary outcomes were mobility (performance-based Short
Physical Performance Battery [SPPB]; continuous version; range 0 to 3; higher score indi-
cates better mobility) and upright time as a proxy measure of physical activity (proportion of
the day upright measured with activPAL) at 6 months. The dataset was analysed using
intention-to-treat principles. The trial was prospectively registered with the Australian New
Zealand Clinical Trials Registry (ACTRN12614000936628). Between 22 September 2014
and 10 November 2016, 300 patients (mean age 74 years, SD 14; 50% female; 54% neuro-
logical condition causing activity limitation) were randomly assigned to intervention (n = 149)
or control (n = 151) using a secure online database (REDCap) to achieve allocation conceal-
ment. Six-month assessments were completed by 258 participants (129 intervention, 129
control). Intervention participants received on average 12 (SD 11) supervised inpatient ses-
sions using 4 (SD 1) different devices and 15 (SD 5) physiotherapy contacts supporting
device use after hospital discharge. Changes in mobility scores were higher in the interven-
tion group compared to the control group from baseline (SPPB [continuous, 0–3] mean
[SD]: intervention group, 1.5 [0.7]; control group, 1.5 [0.8]) to 6 months (SPPB [continuous,
0–3] mean [SD]: intervention group, 2.3 [0.6]; control group, 2.1 [0.8]; mean between-group
difference 0.2 points, 95% CI 0.1 to 0.3; p = 0.006). However, there was no evidence of a dif-
ference between groups for upright time at 6 months (mean [SD] proportion of the day spent
upright at 6 months: intervention group, 18.2 [9.8]; control group, 18.4 [10.2]; mean
between-group difference −0.2, 95% CI −2.7 to 2.3; p = 0.87). Scores were higher in the
intervention group compared to the control group across most secondary mobility out-
comes, but there was no evidence of a difference between groups for most other secondary
outcomes including self-reported balance confidence and quality of life. No adverse events
were reported in the intervention group. Thirteen participants died while in the trial (interven-
tion group: 9; control group: 4) due to unrelated causes, and there was no evidence of a dif-
ference between groups in fall rates (unadjusted incidence rate ratio 1.19, 95% CI 0.78 to
1.83; p = 0.43). Study limitations include 15%–19% loss to follow-up at 6 months on the co-
primary outcomes, as anticipated; the number of secondary outcome measures in our trial,
which may increase the risk of a type I error; and potential low statistical power to demon-
strate significant between-group differences on important secondary patient-reported
outcomes.
Conclusions
In this study, we observed improved mobility in people with a wide range of health conditions
making use of digitally enabled rehabilitation, whereas time spent upright was not impacted.
Digitally-enabled rehabilitation to enhance outcomes: A pragmatic RCT
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Author summary
Why was this study done?
• A higher dose of therapy in physical rehabilitation is associated with better outcomes;
however, current rehabilitation models deliver low therapy doses.
• Use of digital devices such as virtual reality video games, activity monitors, and hand-
held computer devices can be enjoyable, provide feedback on performance, and may
enable a greater dose of task-specific therapy to improve outcomes.
• Current evidence is yet to confidently confirm the effects of rehabilitation using digital
devices in addition to usual rehabilitation care on mobility tasks such as walking and
other important outcomes such as quality of life.
What did the researchers do and find?
• In a pragmatic, outcome-assessor-blinded randomised controlled trial, 300 people with
walking difficulties (age 72 ± 16 years, 50% female) received usual multidisciplinary
inpatient and post-hospital aged care and neurological rehabilitation alone, or in addi-
tion used a range of affordable devices such as virtual reality video games, activity moni-
tors, and handheld devices to target mobility and physical activity, as individually
prescribed by a physiotherapist for 6 months.
• On average participants in the intervention group used 4 ± 1 devices in the inpatient set-
ting and 2 ± 1 devices in the post-hospital setting. This approach was feasible and
enjoyed, and demonstrated it could be provided across care settings including the post-
hospital setting with mostly remote support.
• Clinically important improvement was seen in mobility at 3 weeks and 6 months after
baseline, but this was not accompanied by greater time spent upright.
• No adverse events were reported by participants whilst undertaking rehabilitation using
digital devices, and there was no difference in the rate of falls between groups.
What do these findings mean?
• Digitally enabled rehabilitation using a range of devices prescribed by a physiotherapist
to target a range of mobility limitations across care settings for adults with mixed health
conditions can improve mobility but not time spent upright.
• These results need to be interpreted in light of study limitations including a 15%–19%
loss to follow-up at 6 months on the co-primary outcomes.
Digitally-enabled rehabilitation to enhance outcomes: A pragmatic RCT
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• Future models of rehabilitation should investigate incorporating digital devices to
enhance inpatient and post-hospital rehabilitation, but prescription should ensure qual-
ity and quantity of practice.
Introduction
Over 20% of the world population will be>60 years of age by 2050 [1]. Many will need accessi-
ble and affordable rehabilitation to reduce costly limitations in function from neurological and
musculoskeletal health conditions [2] as well as decline from aging and inactivity [3]. Physical
rehabilitation should contain intensive, repetitive task-specific exercises to improve outcomes
[4–7]. Virtual reality video games, activity monitors, and handheld computer devices are
accessible, affordable, and enjoyable [8], and together can provide a digitally enabled rehabili-
tation environment by providing more opportunity and greater motivation to increase task-
specific practice in hospital [9] and in the home setting [10]. However, evidence of their impact
on outcomes is limited and focused on stroke rehabilitation [11,12]. A systematic review of vir-
tual reality interventions in people after stroke (72 studies) demonstrated a moderate effect on
balance, but no effect on walking speed or global motor function when delivered as an adjunct
to usual rehabilitation [11]. However, the quality of evidence was rated as low for nearly all
outcomes, and all but 1 study tested a single virtual reality system. A feasibility trial conducted
by our team in people undertaking inpatient aged care and neurological rehabilitation (n = 58)
provided an additional dose of rehabilitation for 2 weeks using a range of low-cost video
games and activity monitors [13]. The intervention was feasible, safe, and enjoyable, and
enabled a higher dose of exercise and improved balance but not overall mobility. This promis-
ing intervention, after refinement, required rigorous evaluation.
The primary aim of the Activity and MObility UsiNg Technology (AMOUNT) trial was to
test the effectiveness of tailored prescription of affordable devices to improve mobility and
physical activity in people with mobility limitations undertaking aged care and neurological
rehabilitation. The devices were prescribed in addition to usual care and compared to usual
care alone.
Methods
Design
AMOUNT was a pragmatic, assessor-blinded, multicentre superiority randomised controlled
trial with 2 parallel groups and included a nested economic analysis (presented separately) and
a qualitative study [14].
Sites, staff, and participants
There were 3 trial sites across Australia. Two were in metropolitan hospitals in Sydney in New
South Wales (Site 1: 20-bed stroke and 20-bed aged care rehabilitation wards; Site 2: 16-bed
brain injury rehabilitation unit), and 1 was in Adelaide in South Australia (Site 3: 30-bed geri-
atric evaluation and management ward and 40- and 20-bed general rehabilitation wards).
Research physiotherapists recruited participants, conducted baseline assessments, randomised
participants, and delivered the intervention; all were experienced physiotherapists and
received training in trial processes, as well as in the digital intervention to be delivered.
Digitally-enabled rehabilitation to enhance outcomes: A pragmatic RCT
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Consecutive patients admitted to the units who met the following criteria were invited to
participate:�18 years old; reduced mobility (Short Physical Performance Battery [SPPB]
score < 12) [15] with clinician-assessed capacity for improvement (based on the usual care
physiotherapists’ clinical experience and their assessment and treatment experience with the
patient); life expectancy > 12 months; anticipated length of stay� 10 days from randomisa-
tion; and able to maintain a standing position (with assistance of 1 person if necessary).
Patients were excluded if they had any of the following: cognitive impairment likely to interfere
with device use; insufficient English language skills with no available interpreter; inadequate
vision to use devices; medical condition(s) precluding exercise; no interest in using devices;
anticipated discharge to high care residential facility (nursing home); or discharge location too
distant for follow-up.
Randomisation
A staff member external to the trial prepared the randomisation schedule using randomly per-
muted block sizes of 2, 4, and 6 and incorporating stratification for study site and health condi-
tion (whether or not the person had a neurological health condition affecting mobility).
Following written informed consent and baseline assessment, research staff completed web-
based randomisation (allocation concealment) to determine group allocation.
Intervention
Both the intervention and control groups received usual rehabilitation care, which was deter-
mined by the treating clinicians and included assessment and prescription of a series of repeti-
tive exercises by the physiotherapist, tailored management by the multidisciplinary team, and
a fall prevention brochure [16] (see Table 1). In addition, the intervention group was pre-
scribed 30 to 60 minutes of digitally enabled rehabilitation 5 days per week in hospital and
post-discharge, defined as rehabilitation using digital devices (e.g., virtual reality, wearables,
and tablet and smartphone applications), with remote monitoring and communication post-
discharge. The intervention group was prescribed exercises using virtual reality video games,
activity monitors, and handheld computer devices to enhance mobility and physical activity.
The exercises and devices were individually prescribed by a trial physiotherapist according to
an intervention protocol that matched different task-specific exercises on different devices to
common mobility limitations. The physiotherapist also considered participant impairments
(e.g., upper limb weakness, hemianopia) and contextual factors such as participant goals,
device preferences, and the home environment. Included devices were purchased by the
research team or constructed for less than US$3,700 each. Participants could use any number
of devices as guided by the physiotherapist. Devices were loaned to participants to use at home
and were progressed or changed as required. For further details of usual care and the addi-
tional intervention using digital devices, see Table 1 and S1 Text, and the published protocol
[17].
Outcome measures
Face-to-face outcome assessments were conducted at 3 weeks and 6 months after randomisa-
tion and by mail or telephone at 12 weeks after randomisation. Outcome assessors were regis-
tered health professionals trained in conducting the outcome assessments, external to the
clinical sites, and blinded to group allocation. The face-to-face assessments were conducted in
the hospital if the participant was still an inpatient, or at the post-hospital-discharge destina-
tion (e.g., home, transitional living unit). Prior to the outcome assessor completing the
Digitally-enabled rehabilitation to enhance outcomes: A pragmatic RCT
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Table 1. Intervention description using the template for intervention description and replication (TIDieR) checklist.
Checklist item Intervention group Control group
Inpatient setting Post-hospital setting Inpatient setting Post-hospital setting
Brief name Digitally enabled rehabilitation in addition to usual care. Usual care.
Why Digital devices potentially provide an affordable way to increase the dose
of practice for better rehabilitation outcomes. Devices such as virtual
reality video games, activity monitors, and handheld computer devices
enhance enjoyment of exercise and provide feedback for motor
relearning.
Pragmatic trial design.
What
Materials for
therapists
A detailed intervention protocol that matched mobility limitations with
different devices and games/exercises within those devices. Training in
health coaching by an external provider or previously trained therapists.
Research managers provided ongoing training on the use of the devices,
clinical reasoning, and health coaching.
Clinical therapists were provided with information on the trial protocol
and asked not to use devices to improve mobility or physical activity as
part of their usual care intervention.
Materials for
participants
Participants were (1) provided with a fall prevention brochure on
discharge from hospital [16]; (2) loaned devices for the duration of the
trial; (3) provided with trial-developed practice sheets and information
sheets on how to use the different devices; (4) prescribed mobility
exercises and/or physical activity using devices in addition to usual care.
Recreational devices: Nintendo Wii (Nintendo, Kyoto, Japan);
Xbox Kinect (Microsoft, Redmond, Washington, US); Fitbit Zip, One,
and Alta (Fitbit, San Francisco, California, US); Garmin Vivofit
(Garmin, Olathe, Kansas, US); Runkeeper mobile phone application
(FitnessKeeper, Boston, Massachusetts, US). Rehabilitation devices:
Humac Balance System (CSMi Solutions, Stoughton, Massachusetts,
US); Fysiogaming (Doctor Kinetic, Amsterdam, the Netherlands).
Investigator-developed devices: Stepping Tiles (University of
Technology Sydney, Sydney, Australia); T-Rex iPad exercise application
(Repatriation General Hospital, Adelaide and Sydney, Australia);
AMOUNT iPad exercise application (University of Sydney, Sydney,
Australia); Walk Forward iPhone application (The George Institute for
Global Health and Telstra Health, Sydney, Australia).
Participants were (1) provided with a fall prevention brochure on
discharge from hospital [16]; (2) provided with inpatient usual care at the
3 study sites involving assessment and prescription of a series of repetitive
exercises (e.g., practice of standing up or stepping); (3) referred to usual
outpatient therapy as clinically required. Usual care also included
assessment and tailored management by medical specialists, nurses,
occupational therapists, speech pathologists, social workers, nutritionists,
orthoptists, and other health professionals as required.
Who provided Physiotherapists employed on the trial. Physiotherapists employed at the
study site hospitals.
No intervention or
physiotherapists employed at the
study site hospitals or private
physiotherapists.
How Face-to-face sessions. Face-to-face and remote sessions
following a health coaching model.
A mix of one-on-one, semi-
supervised, independent, and group-
based sessions.
Where Inpatient rehabilitation
gym.
Remotely by phone/email/video
conferencing or in person at the
participant’s discharge destination (home,
transitional living unit, residential care).
Inpatient rehabilitation gym. No intervention or outpatient
rehabilitation gym, at the
participant’s discharge destination
or in the community.
When and how
much
�5 times per week for�30
minutes per session with
physiotherapy supervision
or monitoring.
�5 times per week for�30 minutes per
session independently or with carer
support. Research physiotherapists
provided support using health coaching
model every 1–2 weeks depending on
participant needs and preferences.
Participants were seen as required by
their treating physiotherapist:
typically, �1 session per day Monday
to Friday (and weekends for 1 site).
Participants who required
ongoing physiotherapy were seen
by outpatient/domiciliary
physiotherapy services as
required.
Tailoring The intervention was tailored for each participant to address current
mobility limitations and physical inactivity, considering participant
goals, device preferences, and contextual factors (e.g., home
environment).
Determined by treating physiotherapist.
(Continued)
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6-month assessment, the intervention devices were removed from participant homes and par-
ticipants were reminded not to discuss their trial involvement with the assessor.
Primary outcomes. The co-primary outcomes were mobility and physical activity
(upright time) 6 months after randomisation. Mobility is a broad term that is defined as the
ability to move around and change positions, such as to stand up from sitting and to walk.
Mobility was assessed with the performance-based SPPB (continuous version), also known as
the lower extremity continuous summary performance score, which uses actual time taken to
complete mobility tasks [18]. Scores range from 0 (worst performance) to 3 (best performance)
and are based on timed gait speed over 4 metres; standing balance with feet positioned parallel,
semi-tandem, and tandem; and standing up from a chair 5 times. The SPPB has high levels of
validity, reliability, and responsiveness in measuring mobility in older people living in the
community, is increasingly used in trials involving older adults [19], and can predict falls risk,
disability, and death [20]. The 12-point version of the SPPB is most commonly used, and 0.5-
to 1-point changes have been suggested to be clinically meaningful. We used the continuous
version as it has been suggested as more likely to be able to detect change [18].
Physical activity was assessed over a 7-day period at the end of the 6-month intervention
period using the activPAL activity monitor (PAL Technologies, UK) [21]. The measure of
physical activity was ‘upright time’, defined as the average proportion of the day spent standing
and stepping, measured in 10-second minimum periods. Upright time was chosen as our pri-
mary physical activity measure, rather than steps per day, as not all trial participants were
expected to be able to walk independently, and we sought to use a measure that could be used
at all study time points.
Secondary outcomes. Secondary outcomes were performance-based measures assessed at
3 weeks and 6 months after randomisation and participant-reported measures assessed at 3
and 12 weeks and 6 months after randomisation. Performance-based measures of mobility
included SPPB (continuous) at 3 weeks; SPPB total score (0 to 12 based on categorisation of
performance times; higher score indicates better mobility; clinically important difference 0.5
points) [15,20] and subscale scores (0 to 4) [19]; de Morton Mobility Index (0 to 100; higher
score indicates better mobility; clinically important difference 7 to 8 points) [22–24]; single leg
stance (0 to 10 seconds; greater time indicates better mobility); maximal balance range test
Table 1. (Continued)
Checklist item Intervention group Control group
Inpatient setting Post-hospital setting Inpatient setting Post-hospital setting
Modifications As planned, the intervention protocol was modified during the trial;
version 2 (published 14 October 2015) and version 3 (published 23
February 2016). Modifications included adding new games (e.g., Game
Trainer for Nintendo Wii), a new iPhone application (Walk Forward),
and upgrades of devices (e.g., software updates and rollout of a home-
based version for Fysiogaming). Health coaching was initially prescribed
weekly but changed within the first 6 months of the trial to ‘as required’
with a recommendation of weekly initially, reducing the frequency over
time if the participant was managing well. This was modified due to
experience in the trial and matched the tailored nature of the
intervention (see S2 Text).
Not applicable.
Trial fidelity Fidelity checking by site research managers (LH and MvdB) entailed
observation of intervention sessions (inpatient and community), review
of intervention data sheets with feedback/discussion, site weekly/
fortnightly team meetings, combined-site quarterly meetings with case
studies, practical sessions with devices, review of intervention protocol,
and regular phone meetings between site research managers.
Clinical practice sheets were collected from staff at the 2 sites in New
South Wales (where it was usual practice for therapists to provide practice
sheets) to assess usual physiotherapy care. Participants were questioned
regarding their device use at the time of hospital discharge, and at the end
of the trial intervention.
https://doi.org/10.1371/journal.pmed.1003029.t001
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(millimetres; greater distance indicates better mobility) [25]; and step test (number of steps;
greater number of steps indicates better mobility) [26]. Performance-based measures of physi-
cal activity included proportion of the day spent upright at 3 weeks, average time spent stand-
ing and stepping, number of steps per day, and number of sit to stand transitions per day
measured using the activPAL [21]. Performance-based measures of cognition included Trail
Making Test A, B, and B − A (seconds; quicker time indicates improved cognition) [27,28].
Participant-reported measures included Incidental and Planned Exercise Questionnaire
(IPEQ) total score and home exercise and walking activity subscale scores (hours/week) [29];
Modified Computer Self Efficacy Scale (10 to 100; higher score indicates improved device self-
efficacy) [30]; Activities-specific Balance Confidence Scale (0 to 100; higher score indicates
improved confidence) [31]; WHO Disability Assessment Schedule 2.0 (12 to 60; lower score
indicates improved activity performance and participation) [32,33]; Short Form 6 dimensions
questionnaire subscale scores and health utility score (0 to 1; higher score indicates better qual-
ity of life; mean minimal important difference 0.041) [34,35]; and European Quality of Life–5
dimensions subscale scores, visual analogue scale score (0 to 100), and health utility score
(−0.68 to 1; higher score indicates better quality of life; minimal important difference 0.074)
[35,36]. In addition, falls and health and community service usage were assessed over the
6-month period. Adverse events in the intervention group and deaths in both groups were
monitored and documented throughout the trial. Adverse events were defined as an unwanted
and usually harmful outcome (e.g., fall, seizure, cardiac event) that may or may not be related
to the intervention, but occurred while the participant was undertaking mobility or physical
activities using intervention digital devices. Self-reported measures of device usability (System
Usability Scale; 0 to 100; score above 70 indicates above average usability) [37,38] and enjoy-
ment (Physical Activity Enjoyment Scale; 18 to 126; higher score indicates more enjoyment)
[39] were obtained from the intervention group at 3 and 12 weeks and 6 months after
randomisation.
Data analysis
We estimated that a sample size of 300 participants (150 per group) would provide 90% power
to detect a 15% between-group difference in the co-primary outcome measures, allowing for a
20% dropout rate and an alpha of 5%. This sample size was also estimated to be sufficient to
detect between-group differences of 10%–15% in most secondary outcomes and was consid-
ered by the authors to be of meaningful size on the basis of our collective clinical experience
with the measures.
A statistical analysis plan was approved by the study statistician (SH) and chief investigator
(CS) before data analysis, and no changes were made after this time (see S3 Text). Analysis was
conducted by 2 investigators (CS, LH) blinded to group allocation for the co-primary outcomes
using dummy codes for group allocation, created by a person external to the trial. The dataset
analysed consisted of all randomised participants irrespective of intervention adherence (inten-
tion-to-treat). Missing values were not imputed for the primary analyses. Between-group com-
parisons for continuously scored outcomes were made using linear models with baseline scores
entered as covariates. The distribution of continuous variables was evaluated to inform whether
change scores were used for analysis. Fall rates between groups were compared using negative
binomial regression. Two pre-specified sensitivity analyses were conducted for the co-primary
outcomes; (i) not adjusting for baseline scores and (ii) adjusting for stratification variables. p-
Values were not adjusted for multiplicity as we pre-specified that a significant effect must be
observed on both primary outcomes to declare the intervention effective.
Digitally-enabled rehabilitation to enhance outcomes: A pragmatic RCT
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We undertook 6 pre-specified subgroup analyses based on neurological versus non-neuro-
logical health conditions limiting mobility, sex, age, baseline mobility (SPPB total score),
device use before hospitalisation, and state (New South Wales versus South Australia). The
main analysis for each subgroup analysis was an interaction test in the regression models to
determine whether the effect of treatment differed significantly across categories for that vari-
able. Analyses were performed using Stata software, version 14 (StataCorp).
Fig 1. CONSORT flow diagram. �Number included in intention-to-treat analysis. LOS, length of stay.
https://doi.org/10.1371/journal.pmed.1003029.g001
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Table 2. Characteristics of participants at baseline.
Characteristic Intervention group
n = 149
Control group
n = 151
Demographics
Age (years), mean (SD); range 70 (18); 18–101 73 (15); 21–95
<50, n (%) 21 (14) 15 (10)
50–69, n (%) 44 (30) 38 (25)
70–89, n (%) 73 (49) 85 (57)
90+, n (%) 11 (7) 13 (8)
Sex female, n (%) 72 (48) 77 (51)
Prior living arrangement, n (%)
Alone 58 (39) 46 (31)
Family 89 (60) 102 (68)
Non-relative 2 (1) 3 (1)
Marital status, n (%)
Currently married/cohabitating 70 (47) 77 (51)
Divorced/separated 23 (16) 14 (9)
Widowed 39 (26) 43 (29)
Never married 17 (11) 17 (11)
Years of education, mean (SD); range 12 (3); 5–20 12 (4); 4–32
0–12 years, n (%) 85 (57) 91 (60)
13–16 years, n (%) 39 (26) 36 (24)
>16 years, n (%) 15 (10) 17 (11)
Unknown, n (%) 10 (7) 7 (5)
Current work status, n (%)
Retired 91 (62) 95 (63)
Paid work 27 (18) 22 (15)
Homemaker 6 (4) 14 (9)
Unemployed 14 (9) 10 (7)
Student 5 (3) 2 (1)
Volunteer/other 6 (4) 8 (5)
English primary language at home, n (%) 129 (87) 129 (85)
Health
Neurological condition causing activity limitation, n (%) 80 (54) 82 (54)
Primary diagnosis grouping, n (%)
Neurological 72 (48) 77 (51)
Cardiopulmonary 16 (11) 9 (6)
Musculoskeletal 41 (28) 48 (32)
Restorative care/other 20 (13) 17 (11)
MMSE score (0–30), mean (SD); range 27 (3); 15–30 27 (3); 17–30
Number of co-morbidities (0–26), mean (SD); range 5 (3); 0–14 5 (3); 0–11
Number of medications at entry to study, mean (SD); range 8 (3); 1–19 9 (3); 2–17
Function
Walking status prior to hospitalisation, n (%)
Did not walk 0 (0) 1 (1)
Indoor walker only 17 (11) 20 (13)
Community walker 132 (89) 130 (86)
Devices
Devices used in month prior to hospitalisation, n (%)
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IRB approval
Two human research ethics committees (HRECs) approved the trial (Southern Adelaide Clini-
cal HREC and South Western Sydney Local Health District HREC). Six minor protocol
amendments were approved by the ethics committees, 4 prior to the trial commencing (see S2
Text). We prospectively registered the trial with the Australian New Zealand Clinical Trials
Registry (ACTRN12614000936628).
Results
Between September 2014 and November 2016, 5,039 patients were screened, 715 patients were
assessed as eligible, and 300 patients provided written informed consent and were randomised:
149 to the intervention group and 151 to the control group (Fig 1). Six-month assessments were
completed by 258 participants (control group: 129/151, 85%; intervention group: 129/149,
87%). For the co-primary outcomes, there was an 85% (254/300) follow-up rate for mobility
(data unavailable for 4 additional participants who refused to complete 1 or more test compo-
nents) and an 80% (239/300) follow-up rate for upright time (data missing or excluded for 19
additional participants due to<4 days wear time for activPAL device, n = 3; refusal/unable to
wear device, n = 5; device initialisation/fault, n = 3; device lost, n = 4; missing data, n = 4).
Baseline characteristics are presented in Tables 2 and S1. On average, participants spent 13
days in the ward before randomisation (SD 16; median 8). Participants had a mean age of 74
(SD 14) years, 50% were female, and 54% had neurological health conditions causing activity
limitation. At baseline, participants had significant mobility limitation (mean [SD] SPPB total
score 4.2 [2.6]) and spent little time standing or stepping (mean [SD] upright time 112 [90]
minutes) (Table 3). Prior to hospital admission, 87% of participants could walk independently
in the community and all but 1 could walk indoors. Thirty-nine percent of participants
reported never using a computer, tablet, smartphone, gaming device, or activity monitor in
the month prior to hospitalisation.
Intervention fidelity, acceptability, enjoyment, and adherence
Over the 6-month trial period, participants spent on average 19 days (SD 20; median 12) in an
inpatient setting and 161 days (SD 18) in a post-hospital setting, typically at home. The total
cost of the intervention (staff training, equipment, intervention preparation, and delivery) per
participant was AU$1,892 (S2 Table). Intervention data are presented in Table 4. Intervention
participants rated the usability of prescribed devices above average, and enjoyment as high at
all time points (Table 3).
Participants in both groups received a similar number of usual care physiotherapy sessions
in the post-hospital setting (mean [SD]: intervention group, 10 [15]; control group, 10 [13]
Table 2. (Continued)
Characteristic Intervention group
n = 149
Control group
n = 151
Computer 60 (40) 63 (42)
Tablet 44 (30) 35 (23)
Smartphone 55 (37) 52 (34)
Gaming console 6 (4) 1 (1)
Activity monitor 7 (5) 2 (1)
MMSE, Mini-Mental State Examination.
https://doi.org/10.1371/journal.pmed.1003029.t002
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Table 3. Primary and secondary outcome measures at baseline, 3 weeks, 12 weeks, and 6 months.
Outcome Mean (SD), n
Intervention group Control group
Baseline 3 weeks 12 weeks 6 months Baseline 3 weeks 12 weeks 6 months
Performance-based outcomes
Physical activity (activPAL)
Proportion of the day spent upright (%) 8.0 (6.7) 14.5 (8.4) 18.2 (9.8) 7.5 (5.7) 14.2 (8.6) 18.4 (10.2)
n = 146 n = 135 n = 121 n = 151 n = 141 n = 124
Time spent upright (minutes/day) 115 (96) 208 (122) 262 (142) 109 (83) 204 (124) 265 (147)
n = 146 n = 135 n = 121 n = 151 n = 141 n = 124
Time spent standing (minutes/day) 97 (91) 164 (105) 201 (121) 87 (74) 161 (104) 209 (122)
n = 146 n = 135 n = 121 n = 151 n = 141 n = 124
Time spent stepping (minutes/day) 19 (17) 44 (30) 61 (40) 21 (23) 43 (33) 56 (38)
n = 146 n = 135 n = 121 n = 151 n = 141 n = 124
Number of steps per day 1,107
(1,101)
2,892
(2,144)
4,395
(3,129)
1,315
(1,754)
2,865
(2,590)
3,858
(2,951)
n = 146 n = 135 n = 121 n = 151 n = 141 n = 124
Number of sit to stand transitions per day 36 (18) 42 (14) 43 (16) 38 (24) 43 (19) 41 (15)
n = 146 n = 135 n = 121 n = 151 n = 141 n = 124
Mobility
Short Physical Performance Battery
Continuous (0–3) 1.5 (0.7) 2.1 (0.6) 2.3 (0.6) 1.5 (0.8) 1.8 (0.8) 2.1 (0.8)
n = 149 n = 139 n = 126 n = 149 n = 141 n = 129
Total score (0–12) 4.3 (2.6) 6.7 (2.9) 7.9 (3.1) 4.2 (2.6) 5.8 (3.3) 7.0 (3.4)
n = 149 n = 141 n = 128 n = 151 n = 143 n = 129
Balance subscale (0–4) 2.2 (1.5) 3.0 (1.3) 3.3 (1.1) 2.0 (1.4) 2.6 (1.4) 3.0 (1.3)
n = 149 n = 141 n = 128 n = 151 n = 143 n = 129
Gait speed subscale (0–4) 1.6 (1.1) 2.5 (1.2) 2.9 (1.1) 1.6 (1.2) 2.2 (1.3) 2.7 (1.3)
n = 149 n = 141 n = 128 n = 151 n = 143 n = 129
Chair stand subscale (0–4) 0.5 (0.8) 1.2 (1.3) 1.7 (1.5) 0.6 (1.0) 1.0 (1.2) 1.4 (1.3)
n = 149 n = 141 n = 128 n = 151 n = 143 n = 129
de Morton Mobility Index (0–100) 45.3 (12.2) 58.9 (15.3) 67.4 (18.3) 44.3 (13.4) 54.2 (19.2) 64.4 (19.6)
n = 149 n = 141 n = 128 n = 151 n = 143 n = 128
Single leg stance (0–10 seconds) 1.9 (3.3) 3.7 (4.1) 5.4 (4.3) 2.1 (3.3) 2.9 (3.8) 4.2 (4.2)
n = 149 n = 141 n = 127 n = 151 n = 143 n = 129
Maximal balance range test (millimetres) 101.8 (63.0) 129.2 (64.5) 143.4 (76.8) 97.4 (61.7) 110.8 (69.6) 125.7 (67.1)
n = 149 n = 141 n = 128 n = 151 n = 143 n = 129
Step test (steps, average of both legs) 4.2 (4.9) 7.7 (5.4) 10.1 (5.9) 4.0 (5.0) 6.0 (5.8) 8.2 (6.1)
n = 149 n = 141 n = 128 n = 151 n = 143 n = 129
Cognition†
Trail Making Test A (0–120 seconds) 59.3 (29.5) 45.6 (21.7) 43.3 (22.5) 62.4 (31.7) 51.3 (27.7) 45.1 (22.9)
n = 149 n = 141 n = 128 n = 151 n = 142 n = 127
Trail Making Test B (0–300 seconds) 165.6 (91.8) 121.6 (73.1) 107.7 (69.4) 173.7 (90.8) 127.3 (78.7) 110.4 (62.1)
n = 149 n = 141 n = 128 n = 151 n = 142 n = 126
Trail Making Test B minus A (seconds) 106.3 (74.5) 75.9 (58.8) 64.5 (51.8) 111.3 (71.0) 76.1 (57.0) 65.9 (48.4)
n = 149 n = 141 n = 128 n = 151 n = 142 n = 126
Participant-reported outcome measures
Incidental and Planned Exercise Questionnaire (hours/week)
(Continued)
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Table 3. (Continued)
Outcome Mean (SD), n
Intervention group Control group
Baseline 3 weeks 12 weeks 6 months Baseline 3 weeks 12 weeks 6 months
Total score 20.9 (14.7) 23.0
(16.3)
27.0 (15.3) 19.2 (12.8) 21.9
(18.1)
24.6 (16.1)
n = 140 n = 128 n = 128 n = 143 n = 127 n = 129
Home exercise subscale 1.6 (2.9) 1.5 (2.6) 1.8 (3.2) 1.9 (3.3) 1.5 (2.9) 1.3 (2.4)
n = 140 n = 128 n = 128 n = 143 n = 127 n = 129
Walking activity subscale 2.7 (3.5) 3.3 (4.0) 4.8 (5.8) 1.7 (2.4) 2.3 (4.5) 2.7 (3.6)
n = 140 n = 128 n = 128 n = 143 n = 127 n = 129
Modified Computer Self Efficacy Scale (10–100) 65.0 (22.1) 67.8 (26.8) 66.0
(27.8)
75.1 (24.3) 62.3 (23.6) 70.3 (24.9) 65.4
(26.4)
70.8 (26.1)
n = 149 n = 141 n = 130 n = 129 n = 151 n = 143 n = 132 n = 127
Activities-specific Balance Confidence Scale (0–100) 39.6 (26.6) 51.7 (26.1) 57.3
(26.0)
66.5 (23.6) 36.3 (26.5) 49.7 (27.2) 55.3
(30.2)
62.4 (26.8)
n = 148 n = 141 n = 129 n = 129 n = 151 n = 143 n = 132 n = 128
WHO Disability Assessment Schedule 2.0 (raw score
12–60)†
27.8 (7.8) 25.6 (8.5) 21.8 (7.4) 29.2 (8.2) 26.5 (9.7) 23.1 (8.6)
n = 141 n = 131 n = 129 n = 143 n = 132 n = 128
Short Form 6 dimensions questionnaire
Physical function domain (1–6) 4.4 (1.1) 4.0 (0.9) 3.7 (1.0) 3.6 (1.1) 4.5 (1.1) 4.1 (0.9) 3.8 (1.2) 3.6 (1.2)
n = 149 n = 141 n = 130 n = 129 n = 150 n = 143 n = 132 n = 129
Role limitation domain (1–4) 3.1 (1.1) 3.3 (1.0) 3.2 (1.1) 2.8 (1.1) 3.3 (1.0) 3.1 (1.0) 3.1 (1.1) 2.9 (1.2)
n = 149 n = 141 n = 130 n = 129 n = 150 n = 143 n = 132 n = 129
Social functioning domain (1–5) 3.2 (1.6) 3.2 (1.4) 2.5 (1.3) 2.1 (1.3) 3.3 (1.6) 3.1 (1.6) 2.6 (1.5) 2.3 (1.5)
n = 149 n = 141 n = 130 n = 129 n = 150 n = 142 n = 132 n = 128
Pain domain (1–6) 3.4 (1.8) 3.3 (1.7) 3.2 (1.6) 2.8 (1.4) 3.9 (1.6) 3.2 (1.6) 3.3 (1.5) 3.0 (1.5)
n = 149 n = 141 n = 130 n = 129 n = 150 n = 143 n = 132 n = 129
Mental health domain (1–5) 2.6 (1.2) 2.4 (1.2) 2.3 (1.2) 2.2 (1.2) 2.6 (1.1) 2.6 (1.2) 2.5 (1.2) 2.3 (1.3)
n = 149 n = 141 n = 130 n = 129 n = 150 n = 143 n = 132 n = 129
Vitality domain (1–5) 3.6 (1.3) 3.4 (1.1) 3.3 (1.1) 3.1 (1.0) 3.8 (1.2) 3.6 (1.2) 3.5 (1.1) 3.3 (1.1)
n = 149 n = 141 n = 129 n = 129 n = 150 n = 143 n = 132 n = 129
Health utility (0–1) 0.28 (0.26) 0.32 (0.25) 0.38
(0.24)
0.45 (0.25) 0.22 (0.24) 0.30 (0.26) 0.35
(0.29)
0.42 (0.30)
n = 149 n = 141 n = 129 n = 129 n = 150 n = 142 n = 132 n = 128
EuroQOL-5L
Mobility domain (1–5) 3.0 (1.0) 2.3 (1.0) 2.3 (1.0) 2.0 (1.0) 2.9 (1.1) 2.4 (1.1) 2.5 (1.1) 2.2 (1.0)
n = 149 n = 141 n = 130 n = 129 n = 151 n = 143 n = 132 n = 129
Selfcare domain (1–5) 2.4 (1.2) 1.8 (1.0) 1.7 (0.9) 1.5 (0.9) 2.5 (1.1) 2.0 (1.0) 1.8 (1.1) 1.7 (1.1)
n = 149 n = 141 n = 130 n = 129 n = 151 n = 143 n = 132 n = 129
Usual activities domain (1–5) 3.2 (1.4) 2.7 (1.2) 2.4 (1.2) 1.9 (0.9) 3.5 (1.3) 2.8 (1.3) 2.6 (1.3) 2.1 (1.2)
n = 149 n = 140 n = 130 n = 129 n = 151 n = 143 n = 132 n = 129
Pain or discomfort domain (1–5) 2.4 (1.1) 2.0 (1.0) 2.2 (1.1) 2.0 (0.9) 2.6 (1.1) 2.2 (1.1) 2.3 (1.0) 2.1 (1.0)
n = 149 n = 141 n = 129 n = 129 n = 151 n = 143 n = 132 n = 129
Anxiety or depression domain (1–5) 1.8 (1.0) 1.6 (0.9) 1.7 (0.9) 1.6 (0.9) 1.8 (0.9) 1.7 (0.9) 1.8 (1.0) 1.6 (0.8)
n = 149 n = 141 n = 130 n = 129 n = 151 n = 143) n = 132 n = 129
VAS score (0–100) 54.5 (21.9) 65.7 (18.3) 66.9
(20.8)
71.5 (18.3) 55.0 (20.7) 64.3 (22.1) 67.2
(20.3)
70.2 (20.7)
n = 149 n = 141 n = 130 n = 129 n = 151 n = 143 n = 132 n = 129
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sessions). Few control participants reported using devices for mobility or physical activity
(inpatient setting: computer, n = 1; tablet, n = 2; activity monitor, n = 3; post-hospital setting:
smartphone, n = 1; gaming device, n = 2; activity monitor, n = 9 participants).
Effect of intervention
Co-primary outcomes. Change in mobility scores were higher in the intervention group
compared to the control group from baseline (SPPB [continuous, 0–3] mean [SD]: interven-
tion group, 1.5 [0.7]; control group, 1.5 [0.8]) to 6 months (mean between-group difference 0.2
points, 95% CI 0.1 to 0.3; p = 0.006); however, there was no evidence of a difference between
groups for upright time at 6 months (mean [SD] proportion of the day spent upright at 6
months: intervention group, 18.2 [9.8]; control group, 18.4 [10.2]; mean between-group differ-
ence −0.2, 95% CI −2.7 to 2.3; p = 0.87), with similar results in sensitivity analyses (S3 Table)
and at week 3 (Table 5).
Secondary outcomes. There were between-group differences in favour of the intervention
group across most secondary mobility outcomes (Table 5), for change in self-reported time
spent walking from 3 weeks to 6 months (IPEQ walking activity subscale, hours/week: 1.8,
95% CI 0.6 to 3.0, n = 254; p = 0.004), and for change on 1 measure of cognition from baseline
to 3 weeks (Trail Making Test A: −5.1 seconds, 95% CI −9.3 to −0.8, n = 283; p = 0.02). There
was no evidence of a difference between groups in the number of steps taken per day from
baseline to 6 months (mean between-group difference 646 steps per day, 95% CI −109 to
1,402, n = 239; p = 0.09) or on any other secondary outcomes (Tables 5 and 6 and S4). Thirteen
participants died while in the trial (intervention group: 9; control group: 4) due to causes unre-
lated to the trial. The same number of participants reported falling 1 or more times in both
groups (n = 53), and there was no difference between groups in fall rate (S5 Table). No adverse
events, defined as incidents that occurred while participating in the intervention, were
reported.
Interaction analysis for primary outcomes indicated a greater effect of the intervention on
mobility among those with poorer mobility at baseline (Tables 5 and S6). Exploratory analyses
for secondary outcomes revealed consistently greater intervention impact in younger partici-
pants (Tables 5 and 6 and S7).
Table 3. (Continued)
Outcome Mean (SD), n
Intervention group Control group
Baseline 3 weeks 12 weeks 6 months Baseline 3 weeks 12 weeks 6 months
Health utility score (−0.68 to 1) 0.40 (0.36) 0.60 (0.27) 0.58
(0.29)
0.70 (0.25) 0.36 (0.29) 0.54 (0.31) 0.52
(0.35)
0.65 (0.29)
n = 149 n = 140 n = 129 n = 129 n = 151 n = 143 n = 132 n = 129
System Usability Scale (0–100) 72.2 (18.7) 74.2
(19.8)
78.0 (17.4)
n = 134 n = 123 n = 127
Physical Activity Enjoyment Scale (18–126) 95.5 (23.2) 95.7
(22.0)
98.3 (20.8)
n = 133 n = 122 n = 127
†A lower score indicates a better performance.
EuroQOL-5L, European Quality of Life–5; VAS, visual analogue scale.
https://doi.org/10.1371/journal.pmed.1003029.t003
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Table 4. Intervention group data.
Characteristic Mean (SD), percent, or n (%)
Inpatient (n = 149)
Dose
Number sessions offered 11 (16)#
Number sessions delivered 7 (10)#
Duration of sessions, minutes 41 (11)
Reasons for sessions not delivered
Day of discharge 18%
Feeling tired/unwell 16%
Refusal 11%
Unknown 11%
Public holiday 10%
Devices used
Number of devices 4 (1)
Nintendo Wii 36 (24%)
Xbox Kinect 39 (26%)
Activity monitor (Fitbit, Garmin) 120 (81%)
Smartphone physical activity app 3 (2%)
Fysiogaming 85 (57%)
iPad exercise app 107 (72%)
Humac Balance System 89 (60%)
Stepping Tiles 46 (31%)
Mobility limitations addressed using devices
Maintaining standing position 120 (81%)
Stepping while standing 119 (80%)
Standing up from a chair 114 (77%)
Reaching while standing 67 (45%)
Changing directions while walking 56 (38%)
Stair climbing 25 (17%)
Physical activity through the day 135 (91%)
Community (n = 144)
Dose
Number contacts with physiotherapist 15 (5)
Home visit frequency 6 (1)
Home visit duration, minutes 46 (13)
Phone call frequency 8 (4)
Phone call duration, minutes 8 (3)
Other� frequency 1 (1)
Other� duration, minutes 6 (20)
Reason for physiotherapist contact
Health coaching 68%
Quick contact 20%
Device support 8%
Other 4%
Devices used
Number of devices 2 (1)
Nintendo Wii 23 (16%)
Xbox Kinect 24 (17%)
(Continued)
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Discussion
We conducted a pragmatic, assessor-blinded, parallel-group randomised trial in people with
mobility limitations undertaking aged care and neurological rehabilitation recruited from 3
Australian hospitals to investigate whether tailored prescription of affordable digital devices
(including virtual reality video games, activity monitors, and handheld computer devices) in
addition to usual care could improve mobility and physical activity when compared with peo-
ple undertaking usual care alone. There was no evidence of effectiveness of the intervention in
accordance with our pre-specified definition that both primary outcomes needed to show sta-
tistically significant between-group differences. However, significant and clinically relevant
improvements in mobility were observed in participants receiving the AMOUNT interven-
tion. The greatest improvements in mobility were seen at 3 weeks during hospital-supervised
therapy. Between-group differences were still evident at 6 months despite the lower intensity
physiotherapy support in the post-hospital period. All available devices were used, supporting
our premise of a multi-device intervention over using a single device as in previous studies. Six
of the devices were used across both inpatient and post-hospital care settings, and usability
and enjoyment were rated highly. Taken altogether, these findings suggest that digitally
enabled rehabilitation, supported by physiotherapists, is feasible and acceptable and can
improve mobility outcomes.
The mean between-group difference on our primary mobility measure at 6 months (0.2
points) may be considered of clinical importance. A change of 0.54 on the 12-point version of
the SPPB, i.e., 4.5% of the maximum value, has been suggested to be a small meaningful change
Table 4. (Continued)
Characteristic Mean (SD), percent, or n (%)
Activity monitor (Fitbit, Garmin) 141 (98%)
Smartphone physical activity app 8 (6%)
Fysiogaming (home version) 5 (3%)
iPad exercise app 124 (86%)
Topics covered in health coaching sessions (n = 1,419 sessions)
Objective data from devices 1128 (80%)
Physical activity status 999 (70%)
Mobility status 994 (70%)
Adherence (barriers and facilitators) 909 (64%)
Goal setting and evaluation 662 (47%)
Technical issues and assistance 537 (38%)
Modification of exercise program 495 (35%)
Physical activity/health education 296 (21%)
Fall prevention and education 225 (16%)
Other 210 (15%)
6-month physiotherapist-rated level of adherence
>75% 45 (30%)
50–74% 37 (25%)
25–49% 30 (25%)
1–24% 25 (17%)
0% 7 (5%)
Not rated 5 (3%)
#Median (IQR) values.
�Other: email, video conference, SMS, hospital visit.
https://doi.org/10.1371/journal.pmed.1003029.t004
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Table 5. Primary and secondary performance-based outcomes.
Outcome Time point or time between
assessments
Mean between-group difference (95% CI) in outcome, adjusted for
baseline; n
p-Value
Co-primary outcomes
Mobility (positive MD favours intervention group)
SPPB (continuous version, 0–3) 6 mo minus baseline 0.2 (0.1 to 0.3); 254&,§ 0.006
Physical activity (positive MD favours intervention group)
Proportion of the day spent upright (%) At 6 mo −0.2 (−2.7 to 2.3); 239§ 0.87
Secondary outcomes
Mobility (positive MD favours intervention group)
SPPB
Continuous version (0–3) 3 wk minus baseline 0.3 (0.1 to 0.4); 279& <0.001
Total score (0–12) 3 wk minus baseline 0.9 (0.3 to 1.5); 284¶,& 0.002
6 mo minus baseline 0.9 (0.2 to 1.6); 257¶,#,� ,§ 0.01
Balance subscale score (0–4)~ 3 wk minus baseline 1.9 (1.2 to 3.1); 284 0.007
6 mo minus baseline 1.9 (1.1 to 3.1); 257 0.02
Gait speed subscale score (0–4)~ 3 wk minus baseline 1.5 (1.0 to 2.3); 284 0.07
6 mo minus baseline 1.4 (0.9 to 2.3); 257 0.13
Chair stand subscale score (0–4)~ 3 wk minus baseline 1.9 (1.2 to 3.0); 284 0.006
6 mo minus baseline 1.6 (1.0 to 2.5); 257 0.04
de Morton Mobility Index (0–100) 3 wk minus baseline 4.0 (0.8 to 7.2); 284& 0.02
6 mo minus baseline 2.8 (−1.2 to 6.9); 256‡ 0.17
Single leg stance (0–10 seconds) 3 wk minus baseline 0.9 (0.1 to 1.8); 284 0.03
6 mo minus baseline 1.2 (0.2 to 2.2); 256§ 0.02
Maximal balance range test
(millimetres)
3 wk minus baseline 16.8 (3.2 to 30.4); 284& 0.02
6 mo minus baseline 17.5 (1.6 to 33.4); 257 0.03
Step test (steps, average of both legs) 3 wk minus baseline 1.7 (0.6 to 2.7); 284¶,§ 0.002
6 mo minus baseline 2.0 (0.7 to 3.3); 257 0.003
Physical activity (positive MD favours intervention group)
Proportion of the day spent upright,
percent
At 3wk 0.2 (−1.8 to 2.1); 271 0.86
Time spent upright (minutes/day) At 3wk 2.4 (−25.3 to 30.2); 271 0.86
At 6 mo −3.1 (−39.4 to 33.2); 239§ 0.87
Time spent standing (minutes/day) 3 wk minus baseline 0.7 (−23.1 to 24.5); 271 0.96
6 mo minus baseline −9.3 (−39.7 to 21.1); 239^ 0.55
Time spent stepping (minutes/day) 3 wk minus baseline 3.2 (−3.1 to 9.6); 271 0.32
6 mo minus baseline 6.4 (−3.3 to 16.2); 239#,§ 0.19
Number of steps per day 3 wk minus baseline 238 (−223 to 699); 271^ 0.31
6 mo minus baseline 646 (−109 to 1,402); 239#,§ 0.09
Number of sit to stand transitions per
day
3 wk minus baseline 0 (−4 to 3); 271 0.88
6 mo minus baseline 2 (−2 to 6); 239§ 0.31
Cognition (negative MD favours intervention group)
Trail Making Test A (seconds) 3 wk minus baseline −5.1 (−9.3 to −0.8); 283‡,^ 0.02
6 mo minus baseline −1.3 (−6.6 to 4.0); 255‡ 0.64
Trail Making Test B (seconds) 3 wk minus baseline 0.4 (−12.7 to 13.5); 283‡ 0.95
6 mo minus baseline 4.0 (−10.2 to 18.3); 254 0.58
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[20]. The between-group difference at 6 months in the present study represents 6.7% of the
maximum value for the 3-point version; therefore, it may represent meaningful change.
In the inpatient setting, participants received on average 41 minutes daily of additional
rehabilitation using devices (Table 4). Approximately 60% of participants used the rehabilita-
tion video games (Fysiogaming and the Humac Balance System), which enable the greatest
customisation of task-specific mobility training. Our findings of improved mobility are consis-
tent with previous systematic reviews demonstrating improved activity when a greater amount
of task-specific practice is provided [4,5]. In contrast, our findings of improved mobility are
different than those of the Cochrane systematic review of virtual reality interventions in people
after stroke for the effect of additional virtual reality intervention on global motor function
[11]. This is likely due to our multi-device intervention and detailed intervention protocol,
enabling additional task-specific practice of a range of mobility tasks, compared to the lower
limb trials in the review using 1 device, typically targeting balance. The range of health condi-
tions and inclusion of younger participants in our trial may also explain the different findings;
however, participants with neurological health conditions and participants with worse mobil-
ity at baseline had the greatest improvements in mobility (SPPB total score), particularly at 3
weeks. It is difficult to tease out the contributing role of both amount and type of practice;
however, our results suggest that attention to quality and quantity of rehabilitation practice is
important.
Although the physical capacity of participants in the intervention group to move around
improved, this did not translate to increased time spent upright. Yet there was an indication of
more steps taken by intervention participants (p = 0.09; particularly younger participants, <76
years, p = 0.05), greater self-reported walking, and more time spent stepping and less time
spent standing compared to control participants. This finding matches the way the interven-
tion was delivered, with a focus on increasing the number of steps per day using a Fitbit
tracker, rather than on standing activities. Further exploration of trial activPAL data is under-
way to better understand our findings and to help determine how best to prescribe physical
activity in this population.
The success of the intervention in improving mobility is likely due to the personalisation of
the intervention, which targeted each person’s mobility limitations. The included devices were
Table 5. (Continued)
Outcome Time point or time between
assessments
Mean between-group difference (95% CI) in outcome, adjusted for
baseline; n
p-Value
Trail Making Test B − A (seconds) 3 wk minus baseline 1.7 (−8.7 to 12.0); 283‡ 0.75
6 mo minus baseline 0.1 (−10.3 to 10.5); 254¶ 0.99
Unless otherwise indicated, analyses were conducted with linear regression models with baseline scores entered as covariates. Due to skewed distributions, the change
score between time points was used for all outcomes except proportion of the day spent upright. Confidence intervals have not been adjusted for multiplicity, so
inferences drawn from the intervals may not be reproducible. Between-group differences are presented as odds ratios. Footnotes indicate significant interactions
(p� 0.05) for the following pre-specified variables at the given time points:
#age as a continuous variable;
�age dichotomised at the median (76 years);
&baseline mobility as a continuous variable (SPPB total score);
^prior device use;
§state (New South Wales versus South Australia);
¶health condition (neurological versus non-neurological);
‡sex.
~Analyses conducted with ordered logistic regression for final scores, with baseline scores as a covariate.
MD, mean difference; SPPB, Short Physical Performance Battery.
https://doi.org/10.1371/journal.pmed.1003029.t005
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piloted previously [13], tested by consumer and clinician investigators, and prescribed accord-
ing to a detailed protocol developed by the investigator team using motor learning principles
[40]. The right level of challenge, variety, enjoyment, and support to use the devices appears
key to successful participant engagement [14,41].
Study limitations include 15%–19% loss to follow-up at 6 months on co-primary outcomes,
as anticipated in this age group of hospitalised patients. Multiplicity is also a consideration due
to the number of outcomes measured. Additionally, there was no statistically significant differ-
ence in the important participant-reported outcome of health-related quality of life; however,
the measures of this outcome were in the direction favouring the intervention group, which
may reflect low statistical power to demonstrate significance for this outcome. There was
greater time spent with therapists in the intervention group, which could account for the dif-
ference between groups. However, as this was a pragmatic trial, we consider our choice of
usual care and an enhanced program to be the correct comparison, and our trial found
Table 6. Secondary participant-reported outcomes.
Outcome Time point or time between
assessments
Mean between-group difference (95% CI) in
outcome, adjusted for baseline; n
p-
Value
Incidental and Planned Exercise Questionnaire (positive MD favours
intervention group)
Total score (h/wk) 12 wk minus 3 wk 0.4 (−3.7 to 4.4); 252 0.86
6 mo minus 3 wk 1.9 (−1.7 to 5.6); 254 0.31
Home exercise subscale score (h/wk) 12 wk minus 3 wk 0.1 (−0.6 to 0.8); 252 0.79
6 mo minus 3 wk 0.7 (−0.0 to 1.3); 254# 0.05
Walking activity subscale score (h/wk) 12 wk minus 3 wk 0.7 (−0.3 to 1.6); 252& 0.19
6 mo minus 3 wk 1.8 (0.6 to 3.0); 254 0.004
Modified Computer Self Efficacy Scale (10–100) (positive MD favours
intervention group)
3 wk minus baseline −4.8 (−9.7 to 0.1); 284 0.06
12 wk minus baseline −1.1 (−6.8 to 4.5); 262 0.70
6 mo minus baseline 2.2 (−3.3 to 7.7); 256‡ 0.43
Activities-specific Balance Confidence Scale (0–100) (positive MD
favours intervention group)
3 wk minus baseline 0.6 (−4.7 to 5.8); 283 0.83
12 wk minus baseline 1.2 (−5.1 to 7.5); 260§ 0.71
6 mo minus baseline 4.0 (−1.7 to 9.8); 256 0.17
WHO Disability Assessment Schedule 2.0 (raw score 12–60) (negative
MD favours intervention group)
12 wk minus 3 wk −0.1 (−2.2 to 1.9); 261#,� ,^,§ 0.89
6 mo minus 3 wk −0.7 (−2.5 to 1.1); 255‡,§ 0.46
Short Form 6 dimensions questionnaire (health utility score 0–1)
(positive MD favours intervention group)
3 wk 0.00 (−0.06 to 0.05); 282 0.99
12 wk 0.01 (−0.05 to 0.08); 260§ 0.67
6 mo 0.01 (−0.06 to 0.07); 256‡,§ 0.82
European Quality of Life–5 dimensions (health utility score −0.68 to 1)
(positive MD favours intervention group)
3 wk minus baseline 0.04 (−0.02 to 0.10); 283 0.15
12 wk minus baseline 0.05 (−0.02 to 0.13); 261#,� 0.16
6 mo minus baseline 0.05 (−0.02 to 0.11); 258‡ 0.14
This analysis was conducted using linear regression models with baseline scores entered as covariates. Due to skewed distributions, the change score between time
points was used for all outcomes except the Short Form 6 dimensions questionnaire. Confidence intervals have not been adjusted for multiplicity, so inferences drawn
from the intervals may not be reproducible.
Footnotes indicate significant interactions (p� 0.05) for the following pre-specified variables at the given time points: #age as a continuous variable;
�age dichotomised at the median (76 years);
&baseline mobility as a continuous variable (SPPB total score);
^prior device use;
§state (New South Wales versus South Australia);
¶health condition (neurological versus non-neurological);
‡sex.
MD, mean difference; SPPB, Short Physical Performance Battery.
https://doi.org/10.1371/journal.pmed.1003029.t006
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additional benefits of the enhanced program. Contamination was of concern prior to com-
mencing the study; however, only a small number of control participants reported using
devices for mobility or physical activity. Although the range of devices was a strength, accurate
documentation of dosage was difficult because of differences in the types of output data (e.g.,
game time, repetitions), particularly at home. Development and testing of efficient solutions
such as clinical dashboards that enable data from diverse sources to be integrated into a com-
mon platform [42] may facilitate tailored use and monitoring of multiple devices in
rehabilitation.
Further research should investigate whether future models of rehabilitation care can incor-
porate digital devices to enhance inpatient and post-hospital rehabilitation with a higher dose
of practice whilst conserving quality. Hybrid type II effectiveness–implementation study
designs [43] could be used to simultaneously test the effectiveness of the clinical intervention
(digitally enabled rehabilitation) on patient outcomes and the effectiveness of implementation
strategies (e.g., education and training) to support clinicians to include digital devices into
practice.
In summary, we observed improved mobility in participants with a wide range of health
conditions in a digitally enabled rehabilitation environment, but no between-group differences
in upright time. To enhance generalisability, we focussed on devices likely to be affordable for
most rehabilitation services, with elements that could transfer into the community when the
patient is discharged. Nevertheless, this was a complex intervention, with specialised equip-
ment and expert staff, so further analyses including economic analysis will be important in
understanding its acceptability to purchasers and providers of healthcare.
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